{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T07:13:56Z","timestamp":1791011636840,"version":"4.1.0"},"reference-count":0,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2003,10,2]],"date-time":"2003-10-02T00:00:00Z","timestamp":1065052800000},"content-version":"vor","delay-in-days":2284,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brit J Clinical Pharma"],"published-print":{"date-parts":[[1997,7]]},"abstract":"<jats:p> <jats:italic>Aims<\/jats:italic>\u2007To compare the absorption and clinical effect of spironolactone from an inclusion complex with \u03b2\u2010cyclodextrin (SP\u2010COMP) to Aldactone tablets (ALD) in chronic liver disease.<\/jats:p><jats:p> <jats:italic>Methods<\/jats:italic>\u2007Patients, admitted with chronic liver disease, completed a randomized crossover steady state study. They received their spironolactone dose as either daily SP\u2010COMP or ALD for 7 days. Serial blood samples were drawn over a 24\u2003h period from day 7 of each therapy. Accurate fluid balance was recorded on days 5\u20137 and 12\u201314. Thirteen (six females) whose mean (s.d.) age and weight was 58.4(9.3) years and 74.3(19.0)\u2003kg completed the study.<\/jats:p><jats:p> <jats:italic>Results<\/jats:italic>\u2007The mean (95% confidence limits) relative bioavailability for SP\u2010COMP (compared with ALD) from steady state serum concentrations of canrenone, 6\u03b2\u2010hydroxyl 7\u03b1\u2010thiomethyl spironolactone and 7\u03b1\u2010thiomethyl spironolactone was 310.0 (265.4, 336.7), 233.4(212.9, 250.8) and 254.8(230.8, 279.0)%, respectively. Improvements in clinical status and fluid balance occurred over the last 3 days of SP\u2010COMP with a mean (s.d.) net loss, in fluid balance, of 1370(860)ml compared with a gain of 228(936)ml during ALD.<\/jats:p><jats:p> <jats:italic>Conclusions<\/jats:italic>\u2007Better absorption of spironolactone from the spironolactone: \u03b2\u2010cyclodextrin complex formulation should lead to a reduction in dosage and perhaps a more consistent effect in patients with chronic liver disease.<\/jats:p>","DOI":"10.1046\/j.1365-2125.1997.00626.x","type":"journal-article","created":{"date-parts":[[2003,10,14]],"date-time":"2003-10-14T19:15:11Z","timestamp":1066158911000},"page":"35-39","source":"Crossref","is-referenced-by-count":14,"title":["Improved bioavailability and clinical response in patients with chronic liver disease following the administration of a spironolactone: \u03b2\u2010cyclodextrin complex"],"prefix":"10.1111","volume":"44","author":[{"given":"A. Z. M.","family":"Abosehmah\u2010Albidy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"York","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. S.","family":"Losowsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Chrystyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2003,10,2]]},"container-title":["British Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2125.1997.00626.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2125.1997.00626.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2125.1997.00626.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T06:57:10Z","timestamp":1698389830000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2125.1997.00626.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,7]]},"references-count":0,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1997,7]]}},"alternative-id":["10.1046\/j.1365-2125.1997.00626.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2125.1997.00626.x","archive":["Portico"],"relation":{},"ISSN":["0306-5251","1365-2125"],"issn-type":[{"value":"0306-5251","type":"print"},{"value":"1365-2125","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,7]]}}}